Provexis plc logo  
Provexis discovers, develops and licenses scientifically-
proven
technologies for the global functional food, medical food and
dietary supplement sectors.
 
 
 
     
 

AIM securities in issue and major shareholders

 
 

The Company's issued share capital consists of 1,108,081,929 ordinary shares with a nominal value of 0.1p each ("Ordinary Shares"), each share having equal voting rights.

The Company does not hold any Ordinary Shares in treasury and therefore the number of Ordinary Shares with voting rights is 1,108,081,929.

At 19 February 2010 the following interests of shareholders in excess of 3% have been notified to the Company:
       
 
Number of Ordinary
Shares held
 
Ordinary shares
as % of issued
share capital

In accordance with AIM Rule 26 in so far as the Company is aware the percentage of the Company's issued share capital that is not in public hands is 22.8%.

 
     
 
   
  Bullet Image Share price information
Trade time Loading...  
Latest price Loading...
Price change Loading...
Hemscott Ltd - Disclaimer